Status:
COMPLETED
Effect of Dexmedetomidine Infusion on Post Anesthesia Discharge Time
Lead Sponsor:
Shaukat Khanum Memorial Cancer Hospital & Research Centre
Conditions:
Post Anesthesia Discharge Time in Patients of Breast Cancer Surgery
Eligibility:
FEMALE
18-60 years
Phase:
NA
Brief Summary
A randomised control trial evaluating the effect of low dose dexmedetomidine infusion on post anesthesia discharge time in patients of day case breast cancer surgery compared with placebo infusion. Th...
Detailed Description
A prospective Randomised control trial evaluating the effect of low dose dexmedetomidine infusion on post anesthesia discharge time in patients of day case breast cancer surgery compared with placebo ...
Eligibility Criteria
Inclusion
- Age 18-60 yrs, ASA 1 and 2, elective breast cancer surgery
Exclusion
- BMI greater than 35, CKD stage 3 or greater, known drug allergy to study drug, bradycardia, history of PONV, patients on antiepileptics
Key Trial Info
Start Date :
September 5 2023
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 20 2025
Estimated Enrollment :
82 Patients enrolled
Trial Details
Trial ID
NCT07180810
Start Date
September 5 2023
End Date
August 20 2025
Last Update
September 23 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Shaukat Khanum Memorial Cancer Hospital and Research Centre
Lahore, Pubjab, Pakistan, 54782